1-12 of 12
Mark E Ethell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Limited Efficacy of Ponatinib in Myeloproliferative Neoplasms Associated with FGFR1 Fusion Genes

Sebastian Kreil, MD PhD, Lionel Adès, MD PhD, Martin Bommer, MD, Frank Stegelmann, MD, Mark E Ethell, MBBChir, MA, FRCP, FRCPath, Anna Lubking, MD, Peter Martin, MD, Ekkehard Eigendorff, MD, Wolf-Karsten Hofmann, MD, Nicholas C.P. Cross, PhD, Andreas Hochhaus, MD, Andreas Reiter, MD
Journal: Blood
Blood (2015) 126 (23): 2812.
https://doi.org/10.1182/blood.V126.23.2812.2812
Published: 2015
Journal Articles

Improved Survival in Peripheral T-Cell Lymphoma (PTCL) Following Complete Response to First-Line Chemotherapy: 10 Year Experience at the Royal Marsden and the Christie Hospitals 2002-2012

Mary Gleeson, Kim Linton, Clare Peckitt, Adam Gibb, Eliza A Hawkes, Morgan Back, Binnaz Yasar, Kate Foley, Rebecca Lee, Joanna Dash, Hannah Johnson, Catherine O'Hara, Andrew Wotherspoon, Ayoma Attygalle, Michael Potter, Mark E Ethell, MBBChir, MA, FRCP, FRCPath, Claire Dearden, John Radford, Ian Chau, David Cunningham
Journal: Blood
Blood (2015) 126 (23): 1499.
https://doi.org/10.1182/blood.V126.23.1499.1499
Published: 2015
Journal Articles

The Natural History of Myeloma Patients Who Relapse Early After High Dose Therapy.

Nory Holle, Ping Wu, MBBS, MSc, Charlotte Pawlyn, MD, Radovan Saso, MD, MPhil, PhD, Jennifer G. Treleaven, MD, Michael Potter, MD PhD, Mark E Ethell, MD, Bronwen E. Shaw, MD PhD, Walter M Gregory, PhD, Sandra Croockewit, MD, Gareth J. Morgan, MD PhD, Faith E. Davies, MD
Journal: Blood
Blood (2012) 120 (21): 3125.
https://doi.org/10.1182/blood.V120.21.3125.3125
Published: 2012
Journal Articles

High Absolute T Regulatory Cell Counts and Resistance of CD8 Central Memory Cells to Killing by Fludarabine Predicts for Poor Responses to DLI in the Context of a Pre-DLI Lymphoreduction Strategy

Sameer Tulpule, MBBS, MD, MRCP, Nigel H. Russell, MD, Jenny Byrne, MD, PhD, Emma P Das-Gupta, MD, Mark E Ethell, Daniel Figueroa, J. Alejandro Madrigal, MD, PhD, Gareth J Morgan, MD PhD, Michael Potter, MA, MB, Phd, FRCP, (UK), FRCPath, Bronwen E. Shaw
Journal: Blood
Blood (2011) 118 (21): 1912.
https://doi.org/10.1182/blood.V118.21.1912.1912
Published: 2011
Journal Articles

High Readmission Rates Are Associated with a Significant Economic Burden and Poor Outcome in Patients with Grade 3/4 Acute GvHD

Fiona L Dignan, Michael N Potter, Mark E Ethell, Joy Brennan, Louise McNamara, Stephen O Evans, Claire E. Dearden, Faith E Davies, MD, Gareth J Morgan, MD PhD, Bronwen E. Shaw
Journal: Blood
Blood (2011) 118 (21): 2061.
https://doi.org/10.1182/blood.V118.21.2061.2061
Published: 2011
Journal Articles

The Presence of Minimal Residual Disease Pre- and Post-Transplant Is Predictive of Outcome in Recipients of Allogeneic Transplantation for Acute Myeloid Leukaemia.

Fiona L Dignan, Chloe Anthias, Mark E Ethell, Ricardo Morilla, Alison Morilla, Faith E Davies, MD, Gareth J Morgan, Michael N Potter, Bronwen E Shaw
Journal: Blood
Blood (2009) 114 (22): 2601.
https://doi.org/10.1182/blood.V114.22.2601.2601
Published: 2009
Journal Articles

An Early CT-Diagnosis Based Treatment Strategy for Invasive Fungal Infection in Allogeneic Transplant Recipients Using Caspofungin First Line: An Effective Strategy with Low Mortality.

Fiona L Dignan, Stephen O Evans, Mark E Ethell, Bronwen E. Shaw, Unell BG Riley, Faith Davies, Jennifer G. Treleaven, Claire E. Dearden, Gareth J. Morgan, Michael N Potter
Journal: Blood
Blood (2008) 112 (11): 1149.
https://doi.org/10.1182/blood.V112.11.1149.1149
Published: 2008
Journal Articles

Autologous Transplantation Is the Optimum Approach to the Management of Myeloma Patients with Extramedullary Disease at Presentation

Faith E. Davies, Ping Wu, Kevin Boyd, Radovan Saso, Michael N Potter, Mark E Ethell, Bronwen E Shaw, Jenny Treleaven, Sharon Dines, Gareth J Morgan
Journal: Blood
Blood (2008) 112 (11): 3313.
https://doi.org/10.1182/blood.V112.11.3313.3313
Published: 2008
Journal Articles

Alemtuzumab Administered by Subcutaneous Route Is Less Effective Than Intravenous Route for First Line Therapy of T-Cell Prolymphocytic Leukaemia: Results of a Pilot Study (UKCLL05)

Ami t S Khot, Estella Matutes, MD, PhD, Pawel A Kaczmarek, Mike Hamblin, Ashok Roy, Effie Grand, Mark E Ethell, Claire E Dearden, MD
Journal: Blood
Blood (2008) 112 (11): 4204.
https://doi.org/10.1182/blood.V112.11.4204.4204
Published: 2008
Journal Articles

A Single Institution’s Experience with Allogeneic Haematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukaemia: Analysis of Factors Leading to Improved Outcome

Pawel A Kaczmarek, Michael N Potter, Mark E Ethell, Jennifer G Treleaven, Faith E Davies, Claire E Dearden, Gareth J Morgan, Bronwen E Shaw
Journal: Blood
Blood (2008) 112 (11): 4322.
https://doi.org/10.1182/blood.V112.11.4322.4322
Published: 2008
Journal Articles

Prophylactic Defibrotide in Allogeneic Stem Cell Transplantation: Low Morbidity and Zero Mortality from Veno-Occlusive Disease.

Fiona L. Dignan, BSc, MRCP, Dorothy Gujral, MRCP, Mark E. Ethell, MD MRCP MRCPath, Jennifer Treleaven, FRCP FRCPath, Gareth Morgan, PhD FRCP FRCPath, Michael Potter, PhD FRCP FRCPath
Journal: Blood
Blood (2006) 108 (11): 2968.
https://doi.org/10.1182/blood.V108.11.2968.2968
Published: 2006
Journal Articles

Parainfluenza Virus Type 3 Post Stem Cell Transplant: High Prevalence but Low Mortality.

Fiona L. Dignan, BSc, MRCP, Caroline L. Alvares, BSc, MRCP, MRCPath, Unell Riley, MRCP, Mark E. Ethell, MD, MRCP, MRCPath, David C. Cunningham, MD, FRCP, Jennifer Treleavan, MD, FRCP, FRCPath, Michael Potter, PhD, FRCP, FRCPath
Journal: Blood
Blood (2005) 106 (11): 3229.
https://doi.org/10.1182/blood.V106.11.3229.3229
Published: 2005